About
Biomendex is a Finnish medical technology company founded in 2018 in Tampere by Dr. Kaarlo Paakinaho and Dr. Mikko Manninen. The company specializes in developing and manufacturing advanced synthetic bone graft substitutes aimed at tissue regeneration. Its flagship product line, Adaptos®, includes fully synthetic and biodegradable bone graft substitutes suitable for various surgical applications, such as spinal fusion, oral and maxillofacial surgery, and orthopedic procedures. The products are designed to mimic cancellous bone structure, promoting better bone regeneration and integration with the patient's tissue. Biomendex also offers Adaptos®Vet for veterinary applications, available in Australia and New Zealand. The company collaborates with leading medical institutions, including the Mayo Clinic, to enhance its product offerings and is pursuing FDA approval for Adaptos® in the U.S. market. Biomendex is dedicated to providing surgeons with adaptable medical devices that improve surgical outcomes while minimizing operational risks.
Technologies
Keywords
Company Information
- Employees12
- Founded2018
- Total Funding$2479434
Location
1 Korkeakoulunkatu, Tampere, Pirkanmaa, Finland, 33720
